权衡利拉鲁肽的风险与益处——美国食品药品监督管理局对一种新型抗糖尿病疗法的审评 - Suppr | 超能文献

相似文献

1

Weighing risks and benefits of liraglutide--the FDA's review of a new antidiabetic therapy.权衡利拉鲁肽的风险与益处——美国食品药品监督管理局对一种新型抗糖尿病疗法的审评

N Engl J Med. 2010 Mar 4;362(9):774-7. doi: 10.1056/NEJMp1001578. Epub 2010 Feb 17.

2

Liraglutide and calcitonin.

J Diabetes. 2010 Dec;2(4):223-4. doi: 10.1111/j.1753-0407.2010.00079.x.

3

An analysis of the impact of FDA's guidelines for addressing cardiovascular risk of drugs for type 2 diabetes on clinical development.分析 FDA 针对 2 型糖尿病药物心血管风险的指导原则对临床开发的影响。

Contemp Clin Trials. 2011 May;32(3):324-32. doi: 10.1016/j.cct.2011.01.009. Epub 2011 Jan 23.

4

[The new antidiabetic agents in the firing line.... safety reasons or witch hunt?].

Endocrinol Nutr. 2012 Jan;59(1):1-8. doi: 10.1016/j.endonu.2011.11.002. Epub 2011 Dec 16.

5

Liraglutide (Victoza) for type 2 diabetes.利拉鲁肽（维达列汀）用于2型糖尿病。

Med Lett Drugs Ther. 2010 Apr 5;52(1335):25-7.

6

[Liraglutide: a human GLP-1 analogue for the treatment of diabetes mellitus type 2].利拉鲁肽：一种用于治疗2型糖尿病的人胰高血糖素样肽-1类似物

Med Monatsschr Pharm. 2009 Nov;32(11):402-7.

7

A review of efficacy and safety data regarding the use of liraglutide, a once-daily human glucagon-like peptide 1 analogue, in the treatment of type 2 diabetes mellitus.一项关于每日一次使用利拉鲁肽（一种人胰高血糖素样肽 1 类似物）治疗 2 型糖尿病的疗效和安全性数据的综述。

Clin Ther. 2009 Nov;31(11):2472-88. doi: 10.1016/j.clinthera.2009.11.034.

8

Liraglutide: from clinical trials to clinical practice.利拉鲁肽：从临床试验到临床实践。

Diabetes Obes Metab. 2012 Apr;14 Suppl 2:33-40. doi: 10.1111/j.1463-1326.2012.01576.x.

9

Liraglutide in oral antidiabetic drug combination therapy.利拉鲁肽用于口服抗糖尿病药物联合治疗。

Diabetes Obes Metab. 2012 Apr;14 Suppl 2:13-9. doi: 10.1111/j.1463-1326.2012.01574.x.

10

Late and severe acute necrotizing pancreatitis in a patient with liraglutide.一名使用利拉鲁肽的患者发生迟发性重症急性坏死性胰腺炎。

Therapie. 2012 Nov-Dec;67(6):539-43. doi: 10.2515/therapie/2012076. Epub 2012 Dec 19.

引用本文的文献

1

How multispecific molecules are transforming pharmacotherapy.多特异性分子如何改变药物治疗。

Nat Rev Drug Discov. 2025 Aug 1. doi: 10.1038/s41573-025-01262-w.

2

The role of cell junctions in atherosclerosis: implications for inflammation, endothelial dysfunction, and plaque stability.细胞连接在动脉粥样硬化中的作用：对炎症、内皮功能障碍和斑块稳定性的影响。

J Physiol Biochem. 2025 Jul 4. doi: 10.1007/s13105-025-01106-6.

3

Management of Acquired Hypothalamic Obesity After Childhood-Onset Craniopharyngioma-A Narrative Review.儿童期起病的颅咽管瘤后获得性下丘脑性肥胖的管理——一篇叙述性综述